Latest Daptomycin Stories
On August 9, Cubist Pharmaceuticals, Inc. announced the recall of certain lots of Cubicin (daptomycin for injection) 500 mg due to the presence of particulate matter.
As the FDA announced on April 18, one lot of Cubicin (daptomycin for injection), by Cubist Pharmaceuticals, is recalled due to the presence of particular matter.
Antibiotic-resistant “superbugs” kill approximately 23,000 Americans each year, the US Centers of Disease Control and Prevention (CDC) revealed on Monday.
Infectious diseases specialists from Austin Health are working closely with Microbiologists from the University of Melbourne to understand how Staph is becoming resistant to all antibiotic therapies.
An analysis of the genome of a superbug has yielded crucial, novel information that could aid efforts to counteract the bacterium’s resistance to an antibiotic of last resort.
Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions.
DALLAS, June 27, 2011 /PRNewswire/ -- ReportsnReports announces it will carry 'Daptomycin - Comprehensive patent search'Report in its store Browse the complete 'Daptomycin - Comprehensive patent search [http://www.reportsnreports.com/reports/90113-daptomycin-comprehensive-patent-search.html ] 'Report now! Search 75000+ Market Research Reports [http://www.reportsnreports.com ] Browse All Pharmaceutical Market Research Reports...
LEXINGTON, Mass., June 16, 2011 /PRNewswire-USNewswire/ -- Cubist Pharmaceuticals, Inc. today praised Rep. Phil Gingrey, R-Ga., and co-sponsors for introducing the Generating Antibiotic Incentives Now (GAIN) Bill of 2011.
SAN DIEGO, April 6, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the signing of an exclusive two-year co-promotion agreement to market DIFICID(TM) (fidaxomicin), in the United States.
- A political dynamiter.